January 2025 in “Journal of Cosmetic Dermatology” This literature review discusses exosomes' potential as biomarkers and therapeutics for skin issues, hair loss, and wound healing, but notes that their full functions and standardized applications remain inadequately understood.
January 2025 in “Russian Medical Inquiry” This case study examined the treatment of female-pattern androgenetic alopecia using a protocol combining photodynamic therapy and topical Damask rose stem cell-derived exosomes, suggesting potential benefits for integrating these methods into standard care to enhance therapeutic outcomes and patient satisfaction.
January 2025 in “Journal of Cosmetic Dermatology” This source reported that early evidence supports the potential efficacy of exosomes in treating conditions like alopecia, facial rejuvenation, hyperpigmentation, and scarring, but noted that standardization issues need addressing through further studies to better understand their use in aesthetic dermatology.
This study found that exosomes derived from hair follicle neural crest stem cells significantly promoted nerve regeneration in injured neurons, particularly when overexpressing miR-214-3p, which enhanced axon extension and motor function recovery in both in vitro and in vivo models.
January 2025 in “Open Science Framework” This review critically assesses recent evidence (2020-2025) on the effectiveness of regenerative therapies like platelet-rich plasma, photobiomodulation, stem cells, and exosomes for treating androgenetic alopecia, highlighting the challenges physicians face due to commercialization and the evolving regulatory landscape.
December 2024 in “International Journal of Advanced Research” In this study, researchers compared several commercial products for facial skin repair and found that only the product containing exosomes purified from bovine colostrum showed positive effects on cell proliferation, viability, and wound repair in vitro, outperforming untreated samples and other tested products.
December 2024 in “Journal of Cosmetic Dermatology” This study found that exosomes derived from platelet-rich plasma show preclinical promise for wound healing but lack sufficient data for other dermatological uses like hair growth and skin rejuvenation.
November 2024 in “bioRxiv (Cold Spring Harbor Laboratory)” This study found that exosomes derived from bovine colostrum, compared to those from human stem cells, significantly increased hair follicle growth and regeneration in vitro.
November 2024 in “Comparative Biochemistry and Physiology Part D Genomics and Proteomics” In this study, epithelial cell-derived exosomes promoted fibroblast migration and inhibited their proliferation, suggesting a role in dermal condensate formation and hair follicle morphogenesis in cashmere goats.
November 2024 in “Journal of Translational Internal Medicine” This study found that umbilical cord mesenchymal stem cell-derived exosomes improved hair growth in mice with androgenetic alopecia by promoting hair follicle stem cell stemness through the RAS/ERK pathway, suggesting a potential new treatment strategy for this condition.
October 2024 in “Aesthetic Plastic Surgery” In this multicenter observational study, researchers found that using micrografts with human follicle mesenchymal stem cells increased hair density significantly in both male and female patients with mild to moderate androgenic alopecia after 12 months, suggesting a viable alternative for hair regrowth.
October 2024 in “Dermatologic Surgery” In this review, researchers found that while exosomes show potential for treating hair loss with rare side effects reported among 125 patients, larger clinical trials with consistent manufacturing standards and regulatory oversight are needed to confirm efficacy and ensure safety.
August 2024 in “International Journal of Dermatology” This research commentary discusses the potential role of exosomes in treating hair loss, although no results are reported. The authors highlight prior studies indicating exosomes' promise for hair regeneration and explore their emerging application in dermatology.
August 2024 in “Dermatological Reviews” This review highlights the significant advancements in regenerative medicine from stem cells, PRP, and exosomes for dermatology, but notes that regulatory challenges and the need for standardization are slowing their clinical application.
July 2024 in “Dermatological Reviews” This review discusses the potential benefits of PRP, exosomes, and stem cells in aesthetic medicine, noting the challenges in interpreting study results due to the lack of standardized protocols.
July 2024 in “Acta Histochemica” This study investigates the potential of umbilical cord mesenchymal stem cells exosome (UCMSC-Exos) to promote hair growth, focusing on its mechanisms of action, though specific results are not reported.
July 2024 in “Journal of Nanobiotechnology” This study found that dermal papilla cell-derived exosomes promote hair follicle regeneration during wound healing by enhancing fibroblast activity and activating the Wnt/β-catenin signaling pathway in mice.
July 2024 in “Clinical Cosmetic and Investigational Dermatology” This review summarizes recent advancements in using exosomes for promoting hair growth, finding that exosomes from various cells, like dermal papilla and mesenchymal stem cells, show promise as a potential new treatment route for alopecia.
June 2024 in “Regenerative Therapy” This review highlights the potential of exosomes as a novel therapeutic approach for skin diseases and aging, due to their stability, transportability, and ability to carry various bioactive compounds to target cells.
May 2024 in “Journal of drug delivery science and technology” This review highlights the potential of exosomes, particularly those derived from mesenchymal stromal cells, for treating skin conditions and regeneration, but it also identifies challenges in their production and application.
This abstract introduces "Dermis," an open-access, peer-reviewed journal focused on dermatology, which publishes significant new research in the field of dermatology. Specific research results are not included here.
April 2024 in “Vestnik dermatologii i venerologii” This review highlights the diagnostic potential and therapeutic prospects of exosomes, discussing their use in managing chronic immune-mediated skin conditions, alopecia, and wound healing through their capacity to deliver regulatory molecules between cells.
March 2024 in “Indian Journal of Dermatology/Indian journal of dermatology” This review discusses the potential of exosomes as cell-free treatments for skin aging and various dermatological diseases, highlighting their role in preventing scarring and promoting wound healing, while acknowledging the need for further research and quality control methodologies.
February 2024 in “Journal of Cosmetic Dermatology” White hair patch repigmented and hair regrew in a balding patient after treatment with exosomes and laser.
February 2024 in “Journal of Education, Health and Sport” This review discusses the regenerative properties of exosomes and their potential clinical applications in regenerative medicine, highlighting their role in restoring health and vitality.
February 2024 in “Research Square (Research Square)” In this study, researchers found that exosomes derived from dermal papilla cells can enhance hair follicle regeneration during wound healing in nude mice by promoting fibroblast activation and stimulating the Wnt/β-catenin signaling pathway, suggesting their potential as a therapeutic strategy for regenerative skin healing.
February 2024 in “Skin health and disease” This review reports that exosomes show potential in regenerative and cosmetic dermatology for applications like wound healing and hair loss mitigation, but their clinical use is currently limited by high costs, complex processing, and sparse clinical evidence.
January 2024 in “Biological Research” This study found that mesenchymal stem cell-derived exosomes reduced hearing and hair cell loss caused by neomycin in experimental models by modulating autophagy, which promoted cell survival and lowered oxidative stress and apoptosis, indicating potential for deafness treatment.
January 2024 in “Theranostics” This study found that hypoxia-preconditioned HF-MSC-derived exosomes improved therapeutic outcomes in models of ulcerative colitis, potentially through miR-214-3p-mediated pathways affecting mitochondrial function and inflammatory responses.
January 2024 in “Updates in clinical dermatology” This paper reviews the autoimmune disorder alopecia areata, its progression, and its significant emotional and psychological impact, but reports no new clinical findings.